AI-enabled virtual primary care
InstaDoc
InstaDoc’s current homepage separates informational AI results from optional licensed-clinician care. It describes patient choices over escalation and onward sharing. Earlier pricing, prescribing, and legal findings remain historical because the detailed policies could not be refreshed.
Published September 8, 2026 as an AI-assisted draft. The public report separates documented facts, agency judgments and unresolved questions.
Summary judgment · 82 out of 100 toward patient-directed
Patient-initiated AI intake with optional affiliated clinical care. Preserve the July 30 baseline of 82 and founder-profile submission provenance.
Potentially agency-expanding, with clinical-governance, verification, and disclosure contradictions
InstaDoc’s current homepage separates informational AI results from optional licensed-clinician care. It describes patient choices over escalation and onward sharing. Earlier pricing, prescribing, and legal findings remain historical because the detailed policies could not be refreshed.
Patient agency
How this tool changes agency
Symptom reflection and possible next steps may help patients prepare questions. The claim to use clinical references does not establish visible citations, calibrated uncertainty or validation for a particular answer.
Legal verification requirements, detailed data path, state coverage, final prices, e-prescribing readiness and output correction could not be refreshed.
Patient agency assessment
Who sets and changes the goal?
Patients still define the initial problem and choose clinical escalation. The current homepage makes prepayment review and waiting-time choice more explicit. Whether patients can revise or contest the free AI assessment remains unresolved.
What can the patient understand, question, or do?
Symptom reflection and possible next steps may help patients prepare questions. The claim to use clinical references does not establish visible citations, calibrated uncertainty or validation for a particular answer.
Can the patient evaluate the conditions of use?
Current front-page scope is clearer than the prior urgent-care framing, but anonymity and no-training promises cannot be reconciled against inaccessible policy text in this pass. Clinical and software rights should remain distinct.
Text findings
Why is this tool included?
Brought to HugoScore through a founder-profile screenshot; not an endorsement
A screenshot of founder Jon Pangia's public LinkedIn profile brought InstaDoc to HugoScore's attention on 2026-07-30. The screenshot was treated as a lead, not evidence for product claims. Publishing this draft does not endorse the founder, vendor, medical group, or service.
Conditions of use
Published controls and their limits
Current front-page scope is clearer than the prior urgent-care framing, but anonymity and no-training promises cannot be reconciled against inaccessible policy text in this pass. Clinical and software rights should remain distinct.
What remains unknown?
Not tested or not established
Legal verification requirements, detailed data path, state coverage, final prices, e-prescribing readiness and output correction could not be refreshed.
Who evaluated this?
AI-assisted public-source draft
Vendor statements describe published conditions, not independently verified behavior. No clinical, security, accessibility, or legal validation is claimed. Earlier evidence remains dated in the report and history.
Sources checked
Source-specific findings and retrieval limitations are recorded in the full report.
Review provenance
Criteria
CAIHL-derived HugoScore framework and September 7 qualitative review priorities. Draft v1.2 numerical anchors remain unadopted.
Reviewer
AI-assisted public-source reassessment prepared in OpenAI Codex.
AI / model
OpenAI Codex / GPT-6
Human review
Hugo Campos authorized publication of these AI-assisted draft reassessments on September 8, 2026. This does not claim comprehensive human verification of every finding.
Review date
2026-09-08
Limitations
Legal verification requirements, detailed data path, state coverage, final prices, e-prescribing readiness and output correction could not be refreshed. No live product use, patient-data upload, account creation, code audit, clinical evaluation, or independent implementation validation.
Review method
Focused public-source reassessment using CAIHL: patient authority, critical capacity, and informed control. Existing evidence plus one focused primary-source pass and at most one targeted follow-up. No live product testing. Numerical scores remain provisional editorial placements, not a new calculation.
AI-assisted draft · Low to medium, current homepage only (AI-assisted draft)